TW257676B - - Google Patents

Info

Publication number
TW257676B
TW257676B TW082109831A TW82109831A TW257676B TW 257676 B TW257676 B TW 257676B TW 082109831 A TW082109831 A TW 082109831A TW 82109831 A TW82109831 A TW 82109831A TW 257676 B TW257676 B TW 257676B
Authority
TW
Taiwan
Prior art keywords
homopiperazinyl
ethoxyethyl
benzimidazole
methyl
useful
Prior art date
Application number
TW082109831A
Other languages
English (en)
Chinese (zh)
Original Assignee
Rohto Pharma
Kanebou Textile Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharma, Kanebou Textile Co Ltd filed Critical Rohto Pharma
Application granted granted Critical
Publication of TW257676B publication Critical patent/TW257676B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW082109831A 1992-12-09 1993-11-23 TW257676B (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32921692A JP3527256B2 (ja) 1992-12-09 1992-12-09 抗アレルギー点眼剤

Publications (1)

Publication Number Publication Date
TW257676B true TW257676B (enEXAMPLES) 1995-09-21

Family

ID=18218955

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082109831A TW257676B (enEXAMPLES) 1992-12-09 1993-11-23

Country Status (13)

Country Link
US (1) US5441958A (enEXAMPLES)
EP (1) EP0673250B1 (enEXAMPLES)
JP (1) JP3527256B2 (enEXAMPLES)
KR (1) KR100275016B1 (enEXAMPLES)
AT (1) ATE185696T1 (enEXAMPLES)
AU (1) AU667613B2 (enEXAMPLES)
CA (1) CA2151385C (enEXAMPLES)
DE (1) DE69326840T2 (enEXAMPLES)
DK (1) DK0673250T3 (enEXAMPLES)
ES (1) ES2137352T3 (enEXAMPLES)
GR (1) GR3032264T3 (enEXAMPLES)
TW (1) TW257676B (enEXAMPLES)
WO (1) WO1994013299A1 (enEXAMPLES)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9282799B2 (en) 2012-07-04 2016-03-15 Dyson Technology Limited Attachment for a hand held appliance
US9526310B2 (en) 2012-07-04 2016-12-27 Dyson Technology Limited Attachment for a hand held appliance

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2731618B1 (fr) * 1995-03-14 1997-08-01 Esteve Labor Dr Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
ATE291913T1 (de) * 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
JP2002249445A (ja) * 2000-12-19 2002-09-06 Ophtecs Corp 眼科用液剤組成物
US20040242638A1 (en) * 2001-12-05 2004-12-02 Yanni John M Use of an h1 antagonist and a safe steroid to treat rhinitis
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
LT3740191T (lt) 2018-01-18 2021-08-10 Faes Farma, S.A. Oftalmologinės kompozicijos, apimančios bilastiną, beta-ciklodekstriną ir bent vieną gelinimo agentą

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPH0383924A (ja) * 1989-08-28 1991-04-09 Kanebo Ltd 経皮投与用組成物
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9282799B2 (en) 2012-07-04 2016-03-15 Dyson Technology Limited Attachment for a hand held appliance
US9526310B2 (en) 2012-07-04 2016-12-27 Dyson Technology Limited Attachment for a hand held appliance
US10010150B2 (en) 2012-07-04 2018-07-03 Dyson Technology Limited Attachment for a hand held appliance
US10575617B2 (en) 2012-07-04 2020-03-03 Dyson Technology Limited Attachment for a hand held appliance

Also Published As

Publication number Publication date
ES2137352T3 (es) 1999-12-16
DE69326840D1 (de) 1999-11-25
CA2151385A1 (en) 1994-06-23
JP3527256B2 (ja) 2004-05-17
EP0673250A1 (en) 1995-09-27
DK0673250T3 (da) 1999-12-27
US5441958A (en) 1995-08-15
KR100275016B1 (ko) 2000-12-15
JPH06172179A (ja) 1994-06-21
CA2151385C (en) 1999-02-09
GR3032264T3 (en) 2000-04-27
AU5744294A (en) 1994-07-04
HK1013964A1 (en) 1999-09-17
WO1994013299A1 (en) 1994-06-23
KR940013505A (ko) 1994-07-15
ATE185696T1 (de) 1999-11-15
DE69326840T2 (de) 2000-04-20
EP0673250B1 (en) 1999-10-20
AU667613B2 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
TW257676B (enEXAMPLES)
GEP20033092B (en) Purine Inhibitors of Cyclin Dependent Kinase 2 and Ik-Aa
TR200200160T2 (tr) Antiinflamatuar ajanlar olarak imidazoller ve triazoller
YU9600A (sh) Derivati n-alkanoilfenilalanina
ATE307603T1 (de) Lagerstabile flüssige zusammensetzungen von glucagon-ähnlichem peptid-1
FI946058A7 (fi) Paikalliseen käyttöön tarkoitettu galeeninen koostumus
FI943319A7 (fi) Imidatsolijohdannaiset ja niiden käyttö sytoksiini-inhibiittoreina
GR3035438T3 (en) Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
IL115733A0 (en) Binding agents and their use for therapeutic treatment
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
TR199800415T1 (en) Farmas�tik form�lasyon.
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
DE59511017D1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
ATE410160T1 (de) Fulvinsäure und deren verwendung in der behandlung von entzündungen
ES2113636T3 (es) Trioles sustituidos.
AU2209500A (en) Inhibitors of alpha4beta1 mediated cell adhesion
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
EP1178796A4 (en) AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
DE68916958D1 (de) Topisch angebrachter goldorganokomplex.
IS2860B (is) Veirueyðandi samsetningar
MX9302951A (es) Composicion farmaceutica para tratar la hiperproliferacion celular.
AU645092B2 (en) Anti-actinic agent
ZA91490B (en) Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
NO962619D0 (no) Psoriasisbehandling

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent